First Tracks Analyst Price Targets

Wall Street analyst price targets and consensus rating for First Tracks (TRAX).

Price Target Range — 3 Quarters

Analyst Consensus — 11 Analysts

11Buy

Consensus RatingOverweight# Analysts11Avg. Consensus PT$70Upside to Avg. PT+57.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 16, 2026	Leerink Partners	David Risinger	PT Raise	Outperform	$70→$90
Oct 13, 2026	Canaccord Genuity	Edward Nash	PT Raise	Buy	$50→$60
Oct 13, 2026	Evercore ISI Group	Gavin Clark-Gartner	PT Raise	Outperform	$65→$70
Oct 13, 2026	Wells Fargo	Derek Archila	PT Raise	Overweight	$62→$70
Sep 30, 2026	Canaccord Genuity	Edward Nash	Initiate	Buy	$50
Sep 18, 2026	Evercore ISI Group	Gavin Clark-Gartner	Initiate	Outperform	$65
Sep 16, 2026	Guggenheim	Yatin Suneja	Initiate	Buy	$100
Sep 3, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$57
Aug 13, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$48→$65
Aug 13, 2026	Wedbush	Martin Fan	PT Raise	Outperform	$60→$70
Aug 13, 2026	Piper Sandler	Yasmeen Rahimi	PT Raise	Overweight	$54→$95
Aug 13, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$44→$57
Aug 10, 2026	UBS	Michael Yee	PT Raise	Buy	$45→$65
Jul 28, 2026	Wedbush	Martin Fan	PT Raise	Outperform	$30→$60
Jul 28, 2026	Wells Fargo	Derek Archila	PT Raise	Overweight	$30→$55
Jul 21, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$40→$48
Jul 10, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$30→$44
Jul 8, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$30
Jun 8, 2026	Wells Fargo	Derek Archila	Initiate	Overweight	$30
May 4, 2026	Piper Sandler	Yasmeen Rahimi	Initiate	Overweight	$54

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

Leerink Partners analyst David Risinger maintains First Tracks (NASDAQ:TRAX) with a Outperform and raises the price target from $70 to $90.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60

Canaccord Genuity analyst Edward Nash maintains First Tracks (NASDAQ:TRAX) with a Buy and raises the price target from $50 to $60.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on First Tracks, Raises Price Target to $70

Evercore ISI Group analyst Gavin Clark-Gartner maintains First Tracks (NASDAQ:TRAX) with a Outperform and raises the price target from $65 to $70.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on First Tracks, Raises Price Target to $70

Wells Fargo analyst Derek Archila maintains First Tracks (NASDAQ:TRAX) with a Overweight and raises the price target from $62 to $70.

Benzinga Newsdesk

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

Canaccord Genuity analyst Edward Nash initiates coverage on First Tracks (NASDAQ:TRAX) with a Buy rating and announces Price Target of $50.

Benzinga Newsdesk

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated bullish coverage on TRAX, BGSI, NPCE, CUE and NGVC, assigning Outperform/Buy ratings with price targets from $18 to $120.

Avi Kapoor

First Tracks Biotherapeutics Inc

First Tracks Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

PRO
Canaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60

PRO
Evercore ISI Group Maintains Outperform on First Tracks, Raises Price Target to $70

PRO
Wells Fargo Maintains Overweight on First Tracks, Raises Price Target to $70

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

People Also Watch

People Also Watch

First Tracks Biotherapeutics Inc

First Tracks Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLeerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

PROCanaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60

PROEvercore ISI Group Maintains Outperform on First Tracks, Raises Price Target to $70

PROWells Fargo Maintains Overweight on First Tracks, Raises Price Target to $70

PROCanaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

People Also Watch

People Also Watch

PRO
Leerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

PRO
Canaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60

PRO
Evercore ISI Group Maintains Outperform on First Tracks, Raises Price Target to $70

PRO
Wells Fargo Maintains Overweight on First Tracks, Raises Price Target to $70

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50